|
The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation
|
Oct 2016
|
Biol Blood Marrow Transplant
|
myelodysplastic syndromes (MDS)
|
|
The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications
|
Nov 2020
|
Cells
|
myelodysplastic syndromes (MDS)
|
|
The Genetic Basis and Expanding Role of Molecular Analysis in the Diagnosis, Prognosis, and Therapeutic Design for Myelodysplastic Syndromes
|
Jan 2014
|
J Mol Diagn
|
myelodysplastic syndromes (MDS)
|
|
The evolving role of next generation sequencing in myelodysplastic syndromes
|
Oct 2019
|
British Journal of Haematology
|
myelodysplastic syndromes (MDS)
|
|
The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia
|
Jan 2021
|
Seminars in Hematology
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
|
The Evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
|
Mar 2013
|
Hematology
|
myelodysplastic syndromes (MDS)
|
|
The Efficacy of Current Prognostic Models in Predicting Outcome of Patients with Myelodysplastic Syndromes at the Time of Hypomethylating Agent Failure
|
Mar 2016
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
The Effect of Decitabine Dose Modification and Myelosuppression on Response and Survival in Patients With Myelodysplastic Syndromes
|
May 2014
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
The dysfunction of platelets in paroxysmal nocturnal hemoglobinuria
|
Jul 2016
|
Thromb Res
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q-New prognostic markers are needed
|
Dec 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
